Shannon C. Kenney

Internal Medicine
600 Highland Ave
Madison, WI 53792

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications

Epstein-Barr virus (EBV) infection causes human germinal center B cell-derived lymphomas in the absence of EBNA2 expression.

Epstein-Barr virus (EBV) infection causes human germinal center B cell-derived lymphomas in the absence of EBNA2 expression.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 26, 2026

Epstein-Barr virus type 2 infection is associated with higher viral loads in pediatric tonsils from western Kenya.

Epstein-Barr virus type 2 infection is associated with higher viral loads in pediatric tonsils from western Kenya.

Journal: Microbiology spectrum
Published: July 08, 2025

Epigenetic activation of EBV BGLF4 determines antiviral-based regimen response in EBV+CNS lymphoproliferative disease.

Epigenetic activation of EBV BGLF4 determines antiviral-based regimen response in EBV+CNS lymphoproliferative disease.

Journal: Blood neoplasia
Published: June 27, 2025

IRF6 controls Epstein-Barr virus (EBV) lytic reactivation and differentiation in EBV-infected epithelial cells.

IRF6 controls Epstein-Barr virus (EBV) lytic reactivation and differentiation in EBV-infected epithelial cells.

Journal: PLoS pathogens
Published: December 18, 2024

Development and Preclinical Evaluation of [64Cu]Cu-NOTA-ABDB6: A CD70 and Albumin Dual-Binding Tracer with Improved Pharmacokinetics.

Development and Preclinical Evaluation of [64Cu]Cu-NOTA-ABDB6: A CD70 and Albumin Dual-Binding Tracer with Improved Pharmacokinetics.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 19, 2024

Inhibition of the Integrated stress response by Epstein-Barr virus oncoprotein LMP1 attenuates epithelial cell differentiation and lytic viral reactivation.

Inhibition of the Integrated stress response by Epstein-Barr virus oncoprotein LMP1 attenuates epithelial cell differentiation and lytic viral reactivation.

Journal: PLoS pathogens
Published: September 03, 2024

Human CD4+ iNKT cell adoptive immunotherapy induces anti-tumour responses against CD1d-negative EBV-driven B lymphoma.

Human CD4+ iNKT cell adoptive immunotherapy induces anti-tumour responses against CD1d-negative EBV-driven B lymphoma.

Journal: Immunology
Published: March 04, 2024

Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice.

Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice.

Journal: PLoS pathogens
Published: September 14, 2023

Epstein-Barr virus LMP1 protein promotes proliferation and inhibits differentiation of epithelial cells via activation of YAP and TAZ.

Epstein-Barr virus LMP1 protein promotes proliferation and inhibits differentiation of epithelial cells via activation of YAP and TAZ.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 08, 2023

Effect of Malaria Infection on Epstein-Barr Virus Persistence in Kenyan Children.

Effect of Malaria Infection on Epstein-Barr Virus Persistence in Kenyan Children.

Journal: The Journal of infectious diseases
Published: February 14, 2023

Epstein-Barr virus: Biology and clinical disease.

Epstein-Barr virus: Biology and clinical disease.

Journal: Cell
Published: July 22, 2022

Rta is the principal activator of Epstein-Barr virus epithelial lytic transcription.

Rta is the principal activator of Epstein-Barr virus epithelial lytic transcription.

Journal: PLoS pathogens
Published: June 20, 2022
Showing 1-12 of 52

Last Updated: 09/26/2026